基于BP神經(jīng)網(wǎng)絡(luò)的我國(guó)生物醫(yī)藥企業(yè)創(chuàng)新能力評(píng)價(jià)研究
發(fā)布時(shí)間：2019-05-14 20:34
【摘要】：創(chuàng)新能力對(duì)生物醫(yī)藥企業(yè)發(fā)展至關(guān)重要,本文嘗試將BP神經(jīng)網(wǎng)絡(luò)引入到生物醫(yī)藥上市公司的創(chuàng)新能力評(píng)價(jià)中,探究BP神經(jīng)網(wǎng)絡(luò)在醫(yī)藥產(chǎn)業(yè)創(chuàng)新能力評(píng)價(jià)中是否可行。采用文獻(xiàn)閱讀法,結(jié)合生物醫(yī)藥企業(yè)的實(shí)際情況,建立生物醫(yī)藥企業(yè)創(chuàng)新能力評(píng)價(jià)指標(biāo)體系,利用統(tǒng)計(jì)學(xué)方法構(gòu)建相應(yīng)的BP神經(jīng)網(wǎng)絡(luò),將BP網(wǎng)絡(luò)輸出結(jié)果與期望輸出進(jìn)行比較。采用已建立的創(chuàng)新能力評(píng)價(jià)指標(biāo)體系并利用BP神經(jīng)網(wǎng)絡(luò)對(duì)生物醫(yī)藥企業(yè)的創(chuàng)新能力評(píng)價(jià)的輸出結(jié)果與期望輸出基本一致。將BP神經(jīng)網(wǎng)絡(luò)應(yīng)用于生物醫(yī)藥企業(yè)創(chuàng)新能力評(píng)價(jià)是可行的,所建立的創(chuàng)新能力評(píng)價(jià)指標(biāo)體系基本能夠反映生物醫(yī)藥企業(yè)創(chuàng)新能力。
[Abstract]:Innovation ability is very important to the development of biomedical enterprises. This paper attempts to introduce BP neural network into the evaluation of innovation ability of listed biomedical companies, and to explore whether BP neural network is feasible in the evaluation of innovation ability of pharmaceutical industry. Based on the literature reading method and the actual situation of biomedical enterprises, the evaluation index system of innovation ability of biomedical enterprises is established, and the corresponding BP neural network is constructed by statistical method. The output results of BP network are compared with the expected output. The output results of innovation ability evaluation of biomedical enterprises are basically consistent with the expected output by using the established innovation ability evaluation index system and BP neural network. It is feasible to apply BP neural network to the evaluation of innovation ability of biomedical enterprises. The index system of innovation ability evaluation can basically reflect the innovation ability of biomedical enterprises.
【作者單位】： 中國(guó)藥科大學(xué)國(guó)際醫(yī)藥商學(xué)院;
【基金】：江蘇省“六大人才”高峰項(xiàng)目(YY-013)
【分類號(hào)】：F273.1;F426.72
[Abstract]:Innovation ability is very important to the development of biomedical enterprises. This paper attempts to introduce BP neural network into the evaluation of innovation ability of listed biomedical companies, and to explore whether BP neural network is feasible in the evaluation of innovation ability of pharmaceutical industry. Based on the literature reading method and the actual situation of biomedical enterprises, the evaluation index system of innovation ability of biomedical enterprises is established, and the corresponding BP neural network is constructed by statistical method. The output results of BP network are compared with the expected output. The output results of innovation ability evaluation of biomedical enterprises are basically consistent with the expected output by using the established innovation ability evaluation index system and BP neural network. It is feasible to apply BP neural network to the evaluation of innovation ability of biomedical enterprises. The index system of innovation ability evaluation can basically reflect the innovation ability of biomedical enterprises.
【作者單位】： 中國(guó)藥科大學(xué)國(guó)際醫(yī)藥商學(xué)院;
【基金】：江蘇省“六大人才”高峰項(xiàng)目(YY-013)
【分類號(hào)】：F273.1;F426.72
【參考文獻(xiàn)】
相關(guān)期刊論文 前6條
1 齊秀輝;武志勇;;創(chuàng)新驅(qū)動(dòng)視角下大中型工業(yè)企業(yè)創(chuàng)新能力動(dòng)態(tài)綜合評(píng)價(jià)[J];科技進(jìn)步與對(duì)策;2015年21期
2 徐立平;姜向榮;尹，
本文編號(hào)：2477027
本文鏈接：http://sikaile.net/gongshangguanlilunwen/2477027.html
最近更新
教材專著
